Speciallægeselskabet Allergi- og Lungeklinikken, Odense ApS
CVR number: 40479031
Overstræde 8, 5000 Odense C
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| External services | - 168.71 | ||||
| Gross profit | - 168.71 | - 633.00 | 1 373.76 | 3 982.80 | 4 369.42 |
| Employee benefit expenses | -1 016.16 | -2 485.95 | -2 759.34 | ||
| Total depreciation | - 278.56 | - 638.77 | - 713.69 | - 718.39 | - 718.39 |
| EBIT | - 447.26 | -1 271.77 | - 356.09 | 778.46 | 891.68 |
| Other financial income | 228.44 | ||||
| Other financial expenses | -41.67 | -87.73 | -91.17 | - 142.77 | - 130.72 |
| Net income from associates (fin.) | 897.66 | 2 258.46 | 1 063.20 | 14.32 | |
| Pre-tax profit | 408.73 | 898.95 | 615.94 | 650.00 | 989.41 |
| Income taxes | - 100.88 | - 197.77 | - 117.36 | - 163.80 | - 221.47 |
| Net earnings | 307.85 | 701.18 | 498.58 | 486.20 | 767.94 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Development expenditure | 192.00 | 195.84 | 210.78 | ||
| Goodwill | 3 833.33 | 3 433.33 | 3 033.33 | 2 633.33 | 2 233.33 |
| Intangible assets total | 3 833.33 | 3 433.33 | 3 225.33 | 2 829.17 | 2 444.12 |
| Buildings | 862.50 | 772.50 | 682.50 | 592.50 | 502.50 |
| Machinery and equipment | 1 710.91 | 1 562.14 | 1 775.33 | 1 593.95 | 1 365.56 |
| Tangible assets total | 2 573.41 | 2 334.64 | 2 457.83 | 2 186.45 | 1 868.06 |
| Participating interests | 632.40 | 741.06 | 638.83 | ||
| Investments total | 632.40 | 741.06 | 638.83 | ||
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 415.90 | 303.14 | 229.48 | ||
| Prepayments and accrued income | 1.28 | 19.96 | 135.10 | 19.58 | |
| Current other receivables | 54.77 | 99.00 | 3.79 | ||
| Short term receivables total | 1.28 | 54.77 | 534.86 | 438.25 | 252.85 |
| Other current investments | 945.48 | 1 916.10 | |||
| Cash and bank deposits | 84.63 | 680.19 | 607.39 | 411.87 | 328.31 |
| Cash and cash equivalents | 84.63 | 680.19 | 607.39 | 1 357.35 | 2 244.41 |
| Balance sheet total (assets) | 7 125.06 | 7 243.98 | 7 464.25 | 6 811.22 | 6 809.43 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 |
| Shares repurchased | 110.60 | 113.00 | 114.40 | 117.80 | 122.00 |
| Retained earnings | - 110.60 | 84.25 | 671.04 | 1 051.81 | 1 416.02 |
| Profit of the financial year | 307.85 | 701.18 | 498.58 | 486.20 | 767.94 |
| Shareholders equity total | 347.85 | 938.44 | 1 324.01 | 1 695.82 | 2 345.96 |
| Provisions | 100.88 | 261.05 | 309.04 | 378.32 | 412.31 |
| Non-current loans from credit institutions | 5 548.53 | 5 168.12 | 4 373.62 | ||
| Non-current other liabilities | 3 440.90 | 2 525.97 | |||
| Non-current liabilities total | 5 548.53 | 5 168.12 | 4 373.62 | 3 440.90 | 2 525.97 |
| Current loans from credit institutions | 1 000.00 | 700.00 | 750.00 | 750.00 | 750.00 |
| Current owed to participating | 60.05 | 67.57 | 426.03 | 123.71 | 154.51 |
| Short-term deferred tax liabilities | 37.59 | 67.74 | 86.52 | 161.94 | |
| Other non-interest bearing current liabilities | 67.75 | 71.21 | 213.81 | 335.96 | 458.74 |
| Current liabilities total | 1 127.80 | 876.37 | 1 457.58 | 1 296.19 | 1 525.20 |
| Balance sheet total (liabilities) | 7 125.06 | 7 243.98 | 7 464.25 | 6 811.22 | 6 809.43 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.